{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T08:25:58Z","timestamp":1743063958272,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071614594"},{"type":"electronic","value":"9781071614600"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1460-0_10","type":"book-chapter","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:22:26Z","timestamp":1625682146000},"page":"247-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug Susceptibility Screening Using In Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria"],"prefix":"10.1007","author":[{"given":"Savannah E. R.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A. G.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","volume":"55","author":"LG Wayne","year":"2001","unstructured":"Wayne LG, Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium Tuberculosis. Annu Rev Microbiol 55:139\u2013163","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"10_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/pathogens7040088","volume":"7","author":"SER Gibson","year":"2018","unstructured":"Gibson SER, Harrison J, Cox JAG (2018) Modelling a silent epidemic: a review of the in vitro models of latent tuberculosis. Pathogens 7(4):88. https:\/\/doi.org\/10.3390\/pathogens7040088","journal-title":"Pathogens"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00281-015-0533-1","volume":"38","author":"CJ Martin","year":"2016","unstructured":"Martin CJ, Carey AF, Fortune SM (2016) A bug\u2019s life in the granuloma. Semin Immunopathol 38:213\u2013220","journal-title":"Semin Immunopathol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1385\/1-59259-147-7:247","volume":"54","author":"T Parish","year":"2003","unstructured":"Parish T, Stoker NG, Wayne LG (2003) In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis. Methods Mol Med 54:247\u2013269. https:\/\/doi.org\/10.1385\/1-59259-147-7:247","journal-title":"Methods Mol Med"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","volume":"43","author":"JC Betts","year":"2002","unstructured":"Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43:717\u2013731","journal-title":"Mol Microbiol"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/10409238.2014.895700","volume":"49","author":"MF Wipperman","year":"2014","unstructured":"Wipperman MF, Sampson NS, Thomas ST (2014) Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:269\u2013293","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1084\/jem.20030205","volume":"198","author":"MI Voskuil","year":"2003","unstructured":"Voskuil MI, Schnappinger D, Visconti KC et al (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198:705\u2013713","journal-title":"J Exp Med"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.chembiol.2011.12.016","volume":"19","author":"JE Griffin","year":"2012","unstructured":"Griffin JE, Pandey AK, Gilmore SA et al (2012) Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol 19:218\u2013227","journal-title":"Chem Biol"},{"issue":"5","key":"10_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1084\/jem.20030846","volume":"198","author":"D Schnappinger","year":"2003","unstructured":"Schnappinger D, Ehrt S, Voskuil MI et al (2003) Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the Phagosomal environment. J Exp Med 198(5):693\u2013704. https:\/\/doi.org\/10.1084\/jem.20030846","journal-title":"J Exp Med"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13:e1002152","journal-title":"PLoS Med"},{"key":"10_CR11","unstructured":"WHO (2019) Global TB Rep 2019"},{"issue":"6","key":"10_CR12","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne LG, Hayes LG (1996) An in vitro model for sequential study of Shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64(6):2062\u20132069","journal-title":"Infect Immun"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tube.2005.10.002","volume":"86","author":"SH Cho","year":"2006","unstructured":"Cho SH, Goodlett D, Franzblau S (2006) ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis 86:445\u2013460","journal-title":"Tuberculosis"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1164\/arrd.1977.116.4.627","volume":"116","author":"JM Dickinson","year":"1977","unstructured":"Dickinson JM, Aber VR, Mitchison DA (1977) Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis. Am Rev Respir Dis 116:627\u2013635","journal-title":"Am Rev Respir Dis"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1128\/AAC.00055-06","volume":"51","author":"SH Cho","year":"2007","unstructured":"Cho SH, Warit S, Wan B et al (2007) Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 51:1380\u20131385","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR16","volume-title":"Antibiotics in laboratory medicine","author":"D Amsterdam","year":"2005","unstructured":"Amsterdam D (2005) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 5th edn. Lippincott Williams & Wilkins, PA, USA","edition":"5"},{"key":"10_CR17","first-page":"193","volume":"4","author":"AA Velayati","year":"2011","unstructured":"Velayati AA, Farnia P, Masjedi MR et al (2011) Sequential adaptation in latent tuberculosis bacilli: observation by atomic force microscopy (AFM). Int J Clin Exp Med 4:193\u2013199","journal-title":"Int J Clin Exp Med"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3389\/fmicb.2019.02339","volume":"10","author":"K Jakkala","year":"2019","unstructured":"Jakkala K, Ajitkumar P (2019) Hypoxic non-replicating persistent Mycobacterium tuberculosis develops thickened outer layer that helps in restricting rifampicin entry. Front Microbiol 10:2339","journal-title":"Front Microbiol"}],"container-title":["Methods in Molecular Biology","Mycobacteria Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1460-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:24:29Z","timestamp":1625682269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1460-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071614594","9781071614600"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1460-0_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"8 July 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}